Invesco Ltd. Vista Gen Therapeutics, Inc. Call Options Transaction History
Invesco Ltd.
- $499 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VTGN
# of Institutions
1Shares Held
27.1KCall Options Held
0Put Options Held
0About VistaGen Therapeutics, Inc.
- Ticker VTGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 206,836,000
- Market Cap $556M
- Description
- VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...